BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37792048)

  • 1. In silico identification of a biarylamine acting as agonist at human β
    Soriano-Ursúa MA; Arias-Montaño JA; Ocampo-Néstor AL; Hernández-Martínez CF; Santillán-Torres I; Andrade-Jorge E; Valdez-Ortiz R; Fernández-Del Valle C; Trujillo-Ferrara JG
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2159-2170. PubMed ID: 37792048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The essential role for aromatic cluster in the β3 adrenergic receptor.
    Cai HY; Xu ZJ; Tang J; Sun Y; Chen KX; Wang HY; Zhu WL
    Acta Pharmacol Sin; 2012 Aug; 33(8):1062-8. PubMed ID: 22728712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity and potency of agonists for the three subtypes of cloned human beta-adrenoceptors expressed in Chinese hamster ovary cells.
    Yanagisawa T; Sato T; Yamada H; Sukegawa J; Nunoki K
    Tohoku J Exp Med; 2000 Nov; 192(3):181-93. PubMed ID: 11249148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist effects of zinterol at the mouse and human beta(3)-adrenoceptor.
    Hutchinson DS; Chernogubova E; Sato M; Summers RJ; Bengtsson T
    Naunyn Schmiedebergs Arch Pharmacol; 2006 May; 373(2):158-68. PubMed ID: 16601951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
    Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta3-Adrenergic regulation of an ion channel in the heart-inhibition of the slow delayed rectifier potassium current I(Ks) in guinea pig ventricular myocytes.
    Bosch RF; Schneck AC; Kiehn J; Zhang W; Hambrock A; Eigenberger BW; Rüb N; Gogel J; Mewis C; Seipel L; Kühlkamp V
    Cardiovasc Res; 2002 Dec; 56(3):393-403. PubMed ID: 12445880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist-induced desensitization of human β3-adrenoceptors expressed in human embryonic kidney cells.
    Michel-Reher MB; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Oct; 386(10):843-51. PubMed ID: 23756578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional identification of beta3-adrenoceptors in the guinea-pig ileum using the non-selective beta-adrenoceptor antagonist (+/-)-bupranolol.
    Horinouchi T; Koike K
    J Auton Pharmacol; 2000 Aug; 20(4):253-8. PubMed ID: 11260363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryo-EM structures of the β
    Nureki I; Kobayashi K; Tanaka T; Demura K; Inoue A; Shihoya W; Nureki O
    Biochem Biophys Res Commun; 2022 Jun; 611():158-164. PubMed ID: 35489202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of pharmacological properties and selectivity of SWR-0315NA for beta3-adrenoceptors.
    Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Nagatomo T
    Biol Pharm Bull; 2004 May; 27(5):718-22. PubMed ID: 15133253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists.
    Arch JR
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Aug; 378(2):225-40. PubMed ID: 18612674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivities.
    Sennitt MV; Kaumann AJ; Molenaar P; Beeley LJ; Young PW; Kelly J; Chapman H; Henson SM; Berge JM; Dean DK; Kotecha NR; Morgan HK; Rami HK; Ward RW; Thompson M; Wilson S; Smith SA; Cawthorne MA; Stock MJ; Arch JR
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1084-95. PubMed ID: 9618411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRL37344 stimulates GLUT4 translocation and glucose uptake in skeletal muscle via β
    Mukaida S; Sato M; Öberg AI; Dehvari N; Olsen JM; Kocan M; Halls ML; Merlin J; Sandström AL; Csikasz RI; Evans BA; Summers RJ; Hutchinson DS; Bengtsson T
    Am J Physiol Regul Integr Comp Physiol; 2019 May; 316(5):R666-R677. PubMed ID: 30892909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and beta2-adrenoceptor mechanisms.
    Ngala RA; O'Dowd J; Wang SJ; Agarwal A; Stocker C; Cawthorne MA; Arch JR
    Br J Pharmacol; 2008 Oct; 155(3):395-406. PubMed ID: 18552870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of beta3-adrenoceptor activation on the interaction between adrenoceptors and angiotensin II receptors in apolipoprotein E knockout mouse lung.
    Jiang ZL; Li YF; Song JY; Guo YQ
    Eur J Pharmacol; 2014 Nov; 742():75-80. PubMed ID: 25220245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
    Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X
    Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential
    Adachi N; Hess DT; Kaku M; Ueda C; Numa C; Saito N
    J Biol Chem; 2019 Feb; 294(7):2569-2578. PubMed ID: 30541923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes.
    García-Prieto J; García-Ruiz JM; Sanz-Rosa D; Pun A; García-Alvarez A; Davidson SM; Fernández-Friera L; Nuno-Ayala M; Fernández-Jiménez R; Bernal JA; Izquierdo-Garcia JL; Jimenez-Borreguero J; Pizarro G; Ruiz-Cabello J; Macaya C; Fuster V; Yellon DM; Ibanez B
    Basic Res Cardiol; 2014 Jul; 109(4):422. PubMed ID: 24951958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.
    Dessy C; Moniotte S; Ghisdal P; Havaux X; Noirhomme P; Balligand JL
    Circulation; 2004 Aug; 110(8):948-54. PubMed ID: 15302798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
    Baker JG
    Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.